Performance characteristics of the Mindray chemiluminescence anti‐Müllerian hormone assay

Jing‐Jing Zhao,Chun‐Min Kang,Peng Zhang,Lei Zheng
DOI: https://doi.org/10.1002/jcla.23734
IF: 3.124
2021-03-04
Journal of Clinical Laboratory Analysis
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The aim of this study was to define the performance characteristics of the Mindray chemiluminescence assay for anti‐Müllerian hormone (AMH) detection.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Designs and methods</h3><p>Intra‐assay and total imprecision, analytical sensitivity, linearity, and interference were compared between the Mindray and Roche assays using pools of human serum according to Clinical and Laboratory Standards Institute protocols. Additionally, male and female reference intervals were established using serum specimens collected from otherwise healthy groups and patients with polycystic ovary syndrome (PCOS).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The intra‐assay and total imprecision percent coefficients of variation for low and high AMH serum levels were 2.74%/ 3.01% and 5.41%/5.35% respectively. The limits of blank, detection, and quantitation were 0.007, 0.01, and 0.03 ng/ml, respectively. The assay displayed good linearity over the range of 0.01–23 ng/ml. The coefficient of determination (<i>R</i><sup>2</sup>) of the Mindray versus Roche assays was 0.9713 with 411 samples with AMH concentrations ranging from 0.014 to 22.1 ng/ml. The slope and intercept of the regression equation were 0.9687 and 0.3419, respectively. There was no significant interference from triglycerides (up to 3000 mg/dl), bilirubin (up to 50 mg/dl), hemoglobin (up to 500 mg/dl), or total protein (up to 10 g/dl). Reference intervals showed the expected decrease in serum AMH levels with age in healthy women and increased levels in women with PCOS. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>The Mindray AMH assay demonstrated acceptable analytical performance under routine conditions and is suitable for determining AMH levels in serum samples.</p></section>
medical laboratory technology
What problem does this paper attempt to address?